Evaluating the Efficacy and Safety of Therapeutic Interventions in Sjögren's Syndrome: A Systematic Review Literature

被引:0
|
作者
Cooley, Doris E. [1 ]
Jaramillo, Arturo P. [2 ]
Armijos, Karen N. Munoz [3 ]
机构
[1] Univ Catolica Santiago de Guayaquil, Gen Dent, Guayaquil, Ecuador
[2] Univ Estatal Guayaquil, Gen Practice, Guayaquil, Ecuador
[3] Zaporozhye State Med Univ, Internal Med, Zaporozhe, Ukraine
关键词
hyposalivation; oral health; oral diseases; xerostomia; sjogren and sicca; PRIMARY SJOGRENS-SYNDROME; CLASSIFICATION CRITERIA; AMERICAN-COLLEGE; DATA-DRIVEN; CONSENSUS;
D O I
10.7759/cureus.45751
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In strict accordance with PRISMA 2020 guidelines, our research team conducted a comprehensive systematic literature review (SLR) to explore the treatment and preventive strategies for Sjogren's Syndrome (SS). Leveraging a meticulous search strategy, we scoured reputable databases such as PubMed, PubMed Central, Google Scholar, Web of Science, and The Cochrane Library. Our analysis zeroed in on 10 seminal articles that met our stringent inclusion criteria, providing a holistic view of the existing treatment landscape for SS, along with emerging diagnostic tools and associated biomarkers indicative of lymphoma risk. From a clinical standpoint, our findings unequivocally highlight the detrimental effects of SS on patients' overall well-being. Of particular interest is the growing body of evidence that underscores the effectiveness of natural remedies and over-the-counter supplements rich in antioxidants as viable therapeutic interventions. Contrary to expectations, no single laboratory marker emerged as highly sensitive for the diagnosis of SS. On a promising note, dental implants have been demonstrated to offer lasting benefits with minimal side effects, emphasizing their potential utility in enhancing the oral health of individuals affected by SS. Given the evolving nature of treatment approaches for SS, our review strongly calls for further investigations. Such research endeavors are imperative for validating the effectiveness of these treatment options, whether they serve as primary or preventive care solutions, with the overarching aim of improving the quality of oral health among those suffering from SS.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Neuromyotonia as an unusual neurological complication of primary Sjögren’s syndrome: case report and literature review
    Fei Xiao
    Clinical Rheumatology, 2017, 36 : 481 - 484
  • [32] Cranial Neuropathy As Initial Manifestation of Primary Sjögren's Syndrome: A Case Series With Literature Review
    Lagtarna, Hamza
    Naji, Yahya
    Adali, Nawal
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [33] Sjögren’s syndrome and Neuromyelitis Optica spectrum disorders (NMOSD) - a case report and review of literature
    Apoorva Jayarangaiah
    Rahul Sehgal
    Narendranath Epperla
    BMC Neurology, 14
  • [34] Das Sjögren-SyndromSjögren’s syndrome
    R.E. Schmidt
    T. Witte
    T. Dörner
    Zeitschrift für Rheumatologie, 2010, 69 (1) : 9 - 10
  • [35] Cerebral venous thrombosis as a rare complication of Sjögren's syndrome: case series and literature review
    Liao, Qiuju
    Zhao, Yi
    Li, Xia
    Li, Xuemei
    Huang, Xu
    Su, Li
    CLINICAL RHEUMATOLOGY, 2025, 44 (02) : 739 - 746
  • [36] Ankylosing spondylitis coexists with rheumatoid arthritis and Sjögren’s syndrome: a case report with literature review
    Guo Wang Zhao
    Lin Fang Huang
    Dian Li
    Yan Zeng
    Clinical Rheumatology, 2021, 40 : 2083 - 2086
  • [37] Therapeutic Recommendations for the Management of Older Adult Patients with Sjögren’s Syndrome
    Soledad Retamozo
    Chiara Baldini
    Hendrika Bootsma
    Salvatore De Vita
    Thomas Dörner
    Benjamin A. Fisher
    Jacques-Eric Gottenberg
    Gabriela Hernández-Molina
    Agnes Kocher
    Belchin Kostov
    Aike A. Kruize
    Thomas Mandl
    Wan-Fai Ng
    Raphaèle Seror
    Yehuda Shoenfeld
    Antoni Sisó-Almirall
    Athanasios G. Tzioufas
    Arjan Vissink
    Claudio Vitali
    Simon J. Bowman
    Xavier Mariette
    Manuel Ramos-Casals
    Pilar Brito-Zerón
    Drugs & Aging, 2021, 38 : 265 - 284
  • [38] IL-17, a potential therapeutic target for Sjögren’s syndrome?
    Shan-Shan Liu
    Ye Ding
    Ji-Quan Lou
    Clinical Rheumatology, 2015, 34 : 1657 - 1658
  • [39] Vasculopathy in sjögren's syndrome [Vaskulopathien bei sjögren-syndrom]
    Feist E.
    Hermann K.-G.A.
    Dankof A.
    Zeitschrift für Rheumatologie, 2009, 68 (4) : 305 - 311
  • [40] Melatonin: a potential therapeutic approach for the management of primary Sjögren’s syndrome
    Yi Liu
    Ya-Qin Tan
    Gang Zhou
    Immunologic Research, 2023, 71 : 373 - 387